Temporal Resolution & Sensitivity
Only CellOPTIQ® is able to determine the critical type of EADs present and report on their classification.
Voltage Assay features include:
Proprietary TechnologyClyde’s voltage assay uses proprietary recording techniques and bespoke software to measure transmembrane voltage
Rapid SensingClyde uses a non-toxic ratiometric dye to enable rapid (<1ms) sensing of changes in voltage
Ultra SensitivityCellOPTIQ® can record data at >10 kHz, giving it the ability to detect subtle changes in upstroke kinetics
CiPA StandardsCiPA standardised measurements of action potential
Detailed AnalysisProducing detailed analysis of all action potential phases: upstroke, early-, middle- and late-stage repolarisation
Repeat for up to 20 daysAble to conduct chronic studies with repeated measurements up to 20 days
2D & 3DWorks with 2D or 3D structures
Serum FreeCompounds tested in serum free media avoiding variation of results due to serum
Typical Voltage Data - Cisapride
Below is the output from CellOPTIQ for the action of Cisapride on spontaneously beating hiPSC cardiomyocytes. The data shows a typical response to Cisapride with the prolonging of APD50 and APD90 causing triangulation. Prolongation of ADP90 starts at a concentration, very similar to that seen in humans (QTc). The effects are seen at concentrations within 10 fold of Cmax, therefore Cisapride is designated medium risk of pro arrhythmia.
Assessment of a compound's potential to cause EADs is of vital importance in determining cardiotoxic potential. Older technologies can detect EADs, but only in a presence/absence model. Only CLYDE is able to determine the critical type of EAD present and report on their classification.
Examples of EADs Elucidated on CellOPTIQ®
Start a study with Clyde
To enquire about how Clyde could help with your project complete the enquiry form below and we’ll be get back to you as soon as we can. Alternatively email us at email@example.com